Methoxyeugenol

Methoxyeugenol

SCHEMBL293977

C=CCc1cc(OC)c(O)c(OC)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 1/20 0.73
TNKS2 Q9H2K2 1/20 0.73
ALDH1A1 P00352 5/20 0.66
CYP3A4 P08684 4/20 0.66
PTGS1 P23219 2/20 0.66
TRPM8 Q7Z2W7 2/20 0.66
ALOX5 P09917 1/20 0.66
AR P10275 1/20 0.66
CCR3 P51677 1/20 0.62
PPARG P37231 1/20 0.61
PPARD Q03181 1/20 0.61
PPARA Q07869 1/20 0.61
GABRA1 P14867 4/20 0.54
GABRB2 P47870 4/20 0.54
SMN1; SMN2 Q16637 3/20 0.53
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
KDM4E B2RXH2 1/20 0.51
LMNA P02545 1/20 0.51
GAA P10253 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18338811 0.92 TNKS (0.84) TNKSTNKS2ALDH1A1CYP3A4PTGS1
SCHEMBL30106410 0.92 TNKS (0.84) TNKSTNKS2ALDH1A1CYP3A4PTGS1
SCHEMBL10293953 0.91 TNKS (0.67) TNKSTNKS2ALDH1A1CYP3A4PTGS1
SCHEMBL29448062 0.91 TNKS2 (0.88) TNKSTNKS2ALDH1A1CYP3A4PTGS1
SCHEMBL5320878 0.91 TNKS2 (0.88) TNKSTNKS2ALDH1A1CYP3A4PTGS1
SCHEMBL14151408 0.89 TNKS (0.65) TNKSTNKS2ALDH1A1CYP3A4PTGS1
SCHEMBL6554990 0.89 TNKS (0.65) TNKSTNKS2ALDH1A1CYP3A4PTGS1
SCHEMBL31315838 0.88 TNKS (0.63) TNKSTNKS2ALDH1A1CYP3A4PTGS1
SCHEMBL31238926 0.88 TNKS (0.63) TNKSTNKS2ALDH1A1CYP3A4PTGS1
SCHEMBL31255953 0.88 TNKS (0.63) TNKSTNKS2ALDH1A1CYP3A4PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12543756-B2 Oil and/or fat composition and food or beverage product MIYOSHI OIL & FAT CO., LTD. (JP) 2026-02-10 US claimed
US-20260002924-A1 METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2026-01-01 US claimed
EP-4618780-A1 CONSUMABLE FOR AEROSOLISABLE FORMULATION Nicoventures Trading Limited (GB) 2025-09-24 EP claimed
EP-4618781-A1 CONSUMABLE FOR AEROSOLISABLE FORMULATION Nicoventures Trading Limited (GB) 2025-09-24 EP claimed
EP-4583708-A1 ARTHROPOD CONTROL COMPOSITIONS Firmenich SA (CH) 2025-07-16 EP claimed
US-12351761-B2 Catalytic process OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2025-07-08 US claimed
US-20250206710-A1 COMPOSITIONS AND METHODS RELATED TO THE SIMULTANEOUS MANUFACTURE AND PURIFICATION OF FLAVOR AND FRAGRANCE MOLECULES NATURAL EXTRACTION SYS LLC (US) 2025-06-26 US claimed
CN-120091758-A Arthropod control composition 弗门尼舍有限公司 2025-06-03 CN claimed
US-20250144164-A1 COMPOSITIONS, METHODS, AND MEDICAL COMPOSITIONS FOR TREATMENT OF AND MAINTAINING THE HEALTH OF THE LIVER UNIGEN, INC. (US) 2025-05-08 US claimed
EP-2925139-B1 FERMENTED SOIL ADDITIVE LIQUID FERTILISER SYSTEMS PTY LTD (AU) 2025-04-30 EP claimed
EP-1296569-A1 A METHOD OF PREPARING LIQUID SMOKE Danfo A/S (DK) 2003-04-02 EP claimed
US-6500797-B1 Process for preparing β-ketoester fragrance pro-accords from 1,3-dioxan-4,6-diones THE PROCTER & GAMBLE COMPANY 2002-12-31 US claimed
US-6495243-B1 Recording substrates for ink jet printing XEROX CORPORATION 2002-12-17 US claimed
US-6485841-B1 Bio-oil preservatives ENSYN TECHNOLOGIES, INC. (CA) 2002-11-26 US claimed
WO-2002000040-A1 A METHOD OF PREPARING LIQUID SMOKE DANFO A/S (DK) 2002-01-03 WO claimed
EP-1124671-A1 BIO-OIL PRESERVATIVES Ensyn Technologies Inc. (CA) 2001-08-22 EP claimed
WO-2000025996-A1 BIO-OIL PRESERVATIVES ENSYN TECHNOLOGIES INC. (CA) 2000-05-11 WO claimed
US-5759734-A Method of generating simulated photographic-quality images on luminescent melt-formed backing substrates XEROX CORPORATION (US) 1998-06-02 US claimed
US-4138411-A RUTHENIUM OR OSMIUM CATALYST RHONE-POULENC S. A. (FR) 1979-02-06 US claimed
US-4040970-A WITH COPOLYMER FOR RENDERING THE TONER NEGATIVELY CHARGEABLE CANON KABUSHIKI KAISHA (JA) 1977-08-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260002924-A1 METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS FGB, NR4A1, CYP2E1 TNKS 2177/4885TNKS2 2293/4885ALDH1A1 105/4885
US-12351761-B2 Catalytic process BBOX1, HAAO, HAO2 TNKS 2455/4885TNKS2 2725/4885ALDH1A1 1464/4885
US-12543756-B2 Oil and/or fat composition and food or beverage product TAS2R5, TAS2R8, TAS2R30 TNKS 3627/4885TNKS2 2904/4885ALDH1A1 1207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.